tag:blogger.com,1999:blog-22631442265656617822024-03-05T19:03:35.553-08:00pharmatrendsHere, all pharmacy students and pharmacy professionals can get all the related updates time to time and can became successful in their career. Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.comBlogger39125tag:blogger.com,1999:blog-2263144226565661782.post-85000436047586963452015-07-17T09:27:00.000-07:002015-07-17T09:27:04.267-07:00Cognitive Symptoms in Type 1 Diabetes Patients.<div dir="ltr" style="text-align: left;" trbidi="on">
Clinically significant cognitive impairment is present in more than a quarter of middle-aged adults who had been diagnosed with type 1 diabetes in childhood, according to a new study.<br />
<br />
The results were published online July 7, 2015 in Diabetes Care by Karen A Nunley, PhD, a postdoctoral associate in epidemiology at the University of Pittsburgh, Pennsylvania, and colleagues.<br />
<br />
Wide neuropsychiatric testing among 97 adults with an average age of 49 years who had been diagnosed with type 1 diabetes in childhood revealed a prevalence of 28% of clinically significant cognitive impairment, which is comparable to the prevalence of mild cognitive impairment typically reported in adults aged 85 years and older.<br />
<br />
The finding raises several concerns, Dr. Nunley told Medscape Medical News.<br />
<br />
"We are studying adults who were diagnosed mainly in children, whereas previous studies included individuals diagnosed in adulthood, people who were not exposed to metabolic dysregulation associated with diabetes during critical periods of brain development that occurs during the childhood. "<br />
<br />
And, he said, the issues are also middle aged adults "who are at risk of changes" normal "age-related cognitive, the effects of which may be amplified by long-term exposure to diabetes."<br />
<br />
One explanation could be that chronic hyperglycemia has negative effects on the cerebral vasculature, similar to that known to occur in the retina or the kidney, he said.<br />
<br />
And one of the main concerns is that cognitive impairment can affect a patient's ability to manage their own diabetes. The Poor executive function could hinder time management, the ability to plan and organize, remember details, and to change the approach, Dr. Nunley said, also adding that impaired psychomotor speed may affect the patient's ability to respond quickly to a dangerous situation - for example, while driving.<br />
<br />
However, she also stressed that "we are in no way implying that those with onset type 1 diabetes in children can not become successful adults with significant careers. What we hope to do is raise awareness that cognitive impairment It is a possible complication of diabetes, along the lines of retinopathy and neuropathy, so medical providers can help people with type 1 diabetes and their caregivers understand why this happens. "<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhXJOYryrYYuZdXcSjCOXJmTITuzgRVPxmpFVO5Ozsj8KPfjroEiQfqYpVQp4ctYlMsk3lKVawz4T1CCBxAf4u_5EJGC017IKfQeU7VIbRwbiQNtcxACCaVAHPWV5kMOKget361_knNiqY/s1600/images+%25281%2529.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhXJOYryrYYuZdXcSjCOXJmTITuzgRVPxmpFVO5Ozsj8KPfjroEiQfqYpVQp4ctYlMsk3lKVawz4T1CCBxAf4u_5EJGC017IKfQeU7VIbRwbiQNtcxACCaVAHPWV5kMOKget361_knNiqY/s1600/images+%25281%2529.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">juvenile DM</td></tr>
</tbody></table>
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg_nvaiaFzjEYFbNl87dkuQqEOmvTTmlblC27GpkdF_2i-iRWElDoMZLmykChcEBdXYfznODqKCtgxaoaNGdAKsakqEq-PcnAYBnsU0gf_khD32WBeTrMQi5Q_FyvKATMKqyYUbklEen2I/s1600/images+%25282%2529.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg_nvaiaFzjEYFbNl87dkuQqEOmvTTmlblC27GpkdF_2i-iRWElDoMZLmykChcEBdXYfznODqKCtgxaoaNGdAKsakqEq-PcnAYBnsU0gf_khD32WBeTrMQi5Q_FyvKATMKqyYUbklEen2I/s1600/images+%25282%2529.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Symptoms of DM 1<br /></td></tr>
</tbody></table>
<br /></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-39427024309800351092015-06-19T05:06:00.001-07:002015-06-19T05:06:46.902-07:00Do You Support Maggi????<div dir="ltr" style="text-align: left;" trbidi="on">
Today everybody in the world especially in India are talking about banning of Nestle Maggi and withdrawn of crores of Maggi stock from the market.<br />
<br />
As we know that till 2 decades Maggi became a part of our life. From 2 years children to 60 years old people eating Maggi as their daily food. It is very difficult to withdraw Maggi from the society because people are addicted to it.<br />
<br />
<b>Some reasons why people loving Maggi:</b><br />
1. It is easy to cook.<br />
2. It is tasty<br />
3. Easy to digest<br />
4. As children does not eat vegetables mothers make them to eat vegetables through Maggie.<br />
5. Some body think it is healthy.<br />
6. It is cheaper when compare to other food.<br />
<br />
<b>Government voice towards Maggi:</b><br />
1. Maggie contains more lead than threshold value.<br />
2. Long term consumption of Maggi leads to lead poisoning called as Lead palsy.<br />
3. The symptoms of lead palsy are brain degeneration, body growth restriction etc.,<br />
<br />
<b>Facts about banning of Maggi :</b><br />
1. it might be the government plan to withdraw Maggi from the market to counter the foreign economy. Because Maggie making more marketing in India.<br />
2. Some body telling that it is plan of Maggie against companies.<br />
3. If Maggi contains lead more than threshold value then why we don't find even one case because of lead poisoning.<br />
4. It is very difficult to withdraw any product from the market when the market is at high range.<br />
5. If maggi noodles contains lead what about other noodles. They are also using almost same formula as maggi noodles.<br />
<br />
<b>Alternative steps to decrease lead poisoning instead of banning Maggi:</b><br />
1. All are telling that it is dangerous to children health then it is suggested that the label content of Maggi will be changed to NOT FOR CHILDREN and they should mention age group on label.<br />
2. The effects of the packed content should be printed on label as we seen in case of tablets. Then the people who want to eat they can eat and who don't want avoid it.<br />
3. Parents don't cook Maggie for children below 12 years to avoid lead poisoning.<br />
4. The final important thing is that government has to take steps for research on Maggie poisoning to prove its harmful contents. Then it will be helpful for public and its employees.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjimzClHdmbPLa0ojRqPTLpUOh9kS5zAt0livBU9NHPtoXqPBXay0lpmnkQE5zio2xlB5y-68NZOReMmRtqUaP6cALLNB7TXdeteeoV2exAbKHP_kQK1Optob8Vcm2GDxVXn2qo-L9tgFU/s1600/download.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjimzClHdmbPLa0ojRqPTLpUOh9kS5zAt0livBU9NHPtoXqPBXay0lpmnkQE5zio2xlB5y-68NZOReMmRtqUaP6cALLNB7TXdeteeoV2exAbKHP_kQK1Optob8Vcm2GDxVXn2qo-L9tgFU/s1600/download.jpg" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhCE56TMVyFyfjc_Cq6OdF_CvlRDFxrUpBBwNycz2PuduTfoDVVGntBxDyZtHVZopGyWt-UmOYBMA2lvbjHe9HoyPptljKuNCagWinwE1bjmxN_bPW69UGfCRAfTpSy2SW6rvmmKiXnUUI/s1600/maggie-noodles.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="246" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhCE56TMVyFyfjc_Cq6OdF_CvlRDFxrUpBBwNycz2PuduTfoDVVGntBxDyZtHVZopGyWt-UmOYBMA2lvbjHe9HoyPptljKuNCagWinwE1bjmxN_bPW69UGfCRAfTpSy2SW6rvmmKiXnUUI/s320/maggie-noodles.jpg" width="320" /></a></div>
<br />
<br />
<br />
<br /></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-65468535558475365312015-04-26T22:30:00.000-07:002015-04-26T22:30:40.832-07:00Race for Pharmaceuticals Store Keeper (total 13 seats) throughout India Institute of Medical Sciences<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
All India Institute of Medical Sciences was established as an institution of national importance by an Act of Parliament with the objects to develop patterns of teaching in undergraduate and postgraduate medical education in all its branches to demonstrate a high level of medical education in India ; gather in one place educational facilities of the highest order for the training of personnel in all important branches of health activity; and achieve self-sufficiency in Graduate Medical Education.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Post: Store Keeper, Pharmacist</b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
You are invited in the form prescribed by the online mode to fill various Group "A" (No School), Group 'B' and group messaging "C" at AIIMS, New Delhi as in: -</div>
<div style="text-align: justify;">
(For details, applicants are encouraged to visit www. Aiimsexams.org and read the instructions carefully before completing this form</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Store Keeper (Drugs)</div>
<div style="text-align: justify;">
No.of post: 03- UR</div>
<div style="text-align: justify;">
Group: B</div>
<div style="text-align: justify;">
Pay & pay grade Band: PB-2 Rs.9300-34800 + Grade Pay Rs.4200</div>
<div style="text-align: justify;">
Upper age limit: 25 years</div>
<div style="text-align: justify;">
Essential eligibility criteria:</div>
<div style="text-align: justify;">
(A) essential:</div>
<div style="text-align: justify;">
Degree in Pharmacy from the University Desirable recognized / Institution: -</div>
<div style="text-align: justify;">
Experience in the storage and distribution of medicines in the pharmacy of a hospital or a well established pharmaceutical concern.</div>
<div style="text-align: justify;">
Oregon</div>
<div style="text-align: justify;">
(B) essential:</div>
<div style="text-align: justify;">
(I) for Diploma in Pharmacy / Boards recognized institution;</div>
<div style="text-align: justify;">
(Ii) three years in a hospital pharmacy or a well established pharmaceutical concern.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Pharmaceutical Grade-II</b></div>
<div style="text-align: justify;">
No.of post 10 (UR-04, ST-02, OBC-04) [01-intended PH (OL, BL)]</div>
<div style="text-align: justify;">
Group: C</div>
<div style="text-align: justify;">
Pay & pay grade Band: PB-1 Rs.5200-20200 + Grade Pay Rs.2800)</div>
<div style="text-align: justify;">
Upper age limit: 30 years</div>
<div style="text-align: justify;">
Essential eligibility criteria:</div>
<div style="text-align: justify;">
Essential:</div>
<div style="text-align: justify;">
(I) Degree in Pharmacy from the Institution / Board recognized</div>
<div style="text-align: justify;">
(Ii) In the case of a pharmacist registered under the Pharmacy Act, 1948</div>
<div style="text-align: justify;">
Desirable:</div>
<div style="text-align: justify;">
(I) Degree in Pharmacy from the institution / university recognized</div>
<div style="text-align: justify;">
(Ii) Experience in the supply and / or storage and dispensing of medicines in a hospital or institution or a reputable pharmacy or a pharmaceutical concern.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Online registration application is available at AIIMS www.aiimsexams.org web site from 04/25/2015 to 24/05/2015 9:00 a.m. to 17:00</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
India Institute of Medical Sciences</div>
<div style="text-align: justify;">
ANSARI Nagar, New Delhi-110029</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>PROCUREMENT NOTICE NO. 1/2015</b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
To apply go below link. If the link does not open copy and paste below link in the search box and apply.</div>
<div style="text-align: justify;">
<span style="color: blue;"><u>http://www.davp.nic.in/WriteReadData/ADS/eng_17112_4_1516b.pdf</u></span></div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-66028979243865926762015-04-11T08:10:00.001-07:002015-04-11T08:10:03.788-07:00Be Alert of Sun Stroke<div dir="ltr" style="text-align: left;" trbidi="on">
<b>Sun Stroke:</b><br />
<div style="text-align: justify;">
It is defined as the stroke of heart brought about by excessive heat of sun. It is very common in tropical areas like India at summer season. This is common at summer season i.e,. April to June. This condition may be mild to severe. Some times it is fatal especially for pediatrics and geriatrics.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
So, every one should have knowledge about sun stroke to get rid of its fatal effects. Here I am trying to give little idea about symptoms, causes and first aid of sun stroke.</div>
<br />
<b>Causes of Sun stroke:</b><br />
1. Over working in sun heat (especially between 12 Pm to 4 Pm)<br />
2. Fasting in summer seasons.<br />
3. Lack of water drinking<br />
<br />
<b>Symptoms of sun stroke:</b><br />
1. Over thirsty.<br />
2. Giddiness and fatigue.<br />
3. Palpitation.<br />
4. Dry mouth and dry lips.<br />
5. Fever and diarrhea.<br />
6. Hypotension.<br />
<br />
<b>Effects of sun stroke:</b><br />
1. The common effects are weakness.<br />
2. Some times the effects are fatal like excessive diarrhea.<br />
3. Sudden heart stoke.<br />
<br />
<b>How to detect Sun stroke:</b><br />
If any of the above symptoms were seen in patient we decided that it is sun stroke. The patient looses electrolytes due to sun heat so the blood pressure decreases it may leads to decreasing of blood supply to heart which results heart stroke.<br />
<br />
<b>First aid for sun stroke:</b><br />
1. Patient has brought to cool place immediately.<br />
2. Loosen the body clothes to encourage breathing.<br />
3. Give plenty of water.<br />
4. If possible give ORS.<br />
5. If symptoms are severe take patient to hospital immediately.<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgCl-BmQthV8O7Ajno4zJC0knPU7Fivw92v__Yqwplq6fFoC3Tvj-fx4zd-h10H_LPpYLQoj_o0zgxW0k-vqM85gcZS-dViQgnGdA7DNUB83edGZP0ipkEX8kwh9TeJ9S_cXY-gEbdk5uw/s1600/download+(3).jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgCl-BmQthV8O7Ajno4zJC0knPU7Fivw92v__Yqwplq6fFoC3Tvj-fx4zd-h10H_LPpYLQoj_o0zgxW0k-vqM85gcZS-dViQgnGdA7DNUB83edGZP0ipkEX8kwh9TeJ9S_cXY-gEbdk5uw/s1600/download+(3).jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>ORS</b></td></tr>
</tbody></table>
<br />
<br />
<b>Prevention measures:</b><br />
1. Drink plenty of water.<br />
2. Use umbrellas and caps while going to out side in between 12 Pm to 4 Pm.<br />
3. Take fruit juices, coconut water and fruit juices.<br />
4. Wear cotton clothes.<br />
5. Take rest.<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4rikoHAsMoACmYpbog15x56CP9joMX-7HiNMmhtE9cHMn_yBlr2VD38ZNGNFSM4aNwsMj2UYoEcIB07Fi6QsI_1KQSg_WMiT9b59k-xL-uFjAiqun2gBeJvFJuKVfKfHn4Kz4jbA3-Tc/s1600/download+(1).jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4rikoHAsMoACmYpbog15x56CP9joMX-7HiNMmhtE9cHMn_yBlr2VD38ZNGNFSM4aNwsMj2UYoEcIB07Fi6QsI_1KQSg_WMiT9b59k-xL-uFjAiqun2gBeJvFJuKVfKfHn4Kz4jbA3-Tc/s1600/download+(1).jpg" height="146" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Use Umbrella</b></td></tr>
</tbody></table>
<br /><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: right; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3Y5c2QE-A24iE9ECwuIMPX_b_0bsJB-fSywkfYiVIq4JA3CNeSTtiaMu81UJ1eZB_SuBwPfz-AYudQE7r9LChZodNiGhKjsl6YajT5ySvqIprrdTAuADDMivhG7_PdSFV-PaQp2Q4-Pw/s1600/download.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3Y5c2QE-A24iE9ECwuIMPX_b_0bsJB-fSywkfYiVIq4JA3CNeSTtiaMu81UJ1eZB_SuBwPfz-AYudQE7r9LChZodNiGhKjsl6YajT5ySvqIprrdTAuADDMivhG7_PdSFV-PaQp2Q4-Pw/s1600/download.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Drinking water</b></td></tr>
</tbody></table>
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi2JkQWtT7v1WsoLx4SXVQVYpZ6fSjhybcC5rR4qrS0qpadMn6NREj-Gk1dWcIEshCk5SqNlfdXJa9KctjzCOMCSFyS4fEar0lCD7ceuIOAvBG9FnZ7aOQPkyGLBFJFYlQZ-zJFmgjz_wU/s1600/download+(2).jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi2JkQWtT7v1WsoLx4SXVQVYpZ6fSjhybcC5rR4qrS0qpadMn6NREj-Gk1dWcIEshCk5SqNlfdXJa9KctjzCOMCSFyS4fEar0lCD7ceuIOAvBG9FnZ7aOQPkyGLBFJFYlQZ-zJFmgjz_wU/s1600/download+(2).jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Cotton fabrics </b></td></tr>
</tbody></table>
<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2L3H_-g42NJXFKCb9yJFkCHly2aERcca8WrdyRYFyiSI_cEocFJEBo_le9pOjYG879Bp5tN-CcUqMJ2shjEgDC7c-4yzCQr8mM5KpgAeDxFug-qBqEldiEXrduPyfKraTAtS4eAt1HaM/s1600/ID-10080321.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2L3H_-g42NJXFKCb9yJFkCHly2aERcca8WrdyRYFyiSI_cEocFJEBo_le9pOjYG879Bp5tN-CcUqMJ2shjEgDC7c-4yzCQr8mM5KpgAeDxFug-qBqEldiEXrduPyfKraTAtS4eAt1HaM/s1600/ID-10080321.jpg" height="216" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Add caption</td></tr>
</tbody></table>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br /></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-52368606899971217832015-04-05T01:27:00.000-07:002015-04-05T01:30:59.905-07:00Tips to protect health of Aged parents.<div dir="ltr" style="text-align: left;" trbidi="on">
Parents are the origin of our lives. All of us know that without our parents we are nothing. So the medical care given to them at old age is the real gift to them by us. So we have to take care of their health. But many of us do not know how to protect their health. Here are some tips to save their health. They are;<br />
<br />
1. Medical care:<br />
Sure that your parents having appointments of medical care. Make sure that your parents receiving proper medical care.<br />
<br />
2. Medication safety:<br />
Medication safety is the main part of parents health. So make sure that the medication using by person for any disorder is safe or not.<br />
<br />
3. Physical activity:<br />
We have to encourage our parents to do physical activity at the level best depending on their age.<br />
<br />
4. Mental health:<br />
Observe their mental health like anxiety and depression. If any signs of mental disorder are observed then immediately get proper therapy.<br />
<br />
5. Good nutrition:<br />
Encourage our parents to take healthy and nutrients rich diet to avoid more health problems.<br />
<br />
6. Home improvements.<br />
7. Safety-proofing.<br />
8. Helpful devices.<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhR4PU4L575zo2wBapHwFY0ahq8T6t0Ajyh-FkRnE1hjGH9yze3Ms5bq-73m0FkLah0oFzFaBJ0gwcOZL4IIt138_CJnxztLnIA_dqGBSrTYvcust0TiXA38jBPMqLvLhgeYlYks3QZyG8/s1600/images.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhR4PU4L575zo2wBapHwFY0ahq8T6t0Ajyh-FkRnE1hjGH9yze3Ms5bq-73m0FkLah0oFzFaBJ0gwcOZL4IIt138_CJnxztLnIA_dqGBSrTYvcust0TiXA38jBPMqLvLhgeYlYks3QZyG8/s1600/images.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Medical care </b></td></tr>
</tbody></table>
<br /></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-25103278231095711762015-04-01T07:09:00.000-07:002015-04-01T07:09:19.747-07:00Employment opportunity for B.Pharm cool, M.Pharm Clinical Research Associate: SCRI | 5 Opening<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
The SCRI is an education of a single year and mentoring program for hematology trainees and secondary school teachers in academic medical centers and provides extensive education about clinical research methods, research collaborations, statistical analysis, and management the demands of family and career.<br />
The aim of Saicrinstitute is to produce a group of researchers armed with ideas for hematology and clinical research tools and access to resources for their ideas into reality.<br />
<br />
<b>Message: </b>Clinical Research Associate<br />
<b>No.of Since: </b>05<br />
<br />
<b>Job Description</b><br />
Responsible for management of designated clinical trials including investigator selection, analysis of potential patient recruitment, preparation of documentation related to the trial (protocols, case report forms, brochures researchers, consent documents, letters of agreement, confidentiality agreements), organizing presentations Ethics committee with follow through to ensure successful outcome.<br />
<br />
<b>Required Skills: </b>Pharma, Biotechnology, Microbiology<br />
<b><br /></b>
<b>Candidate profile: </b>MPharm, BPharm, BHMS, BNYS, MBB, M.sc (biotechnology), B.tech (Biotechnology), etc.<br />
<br />
Additional Information:<br />
Exprience: 0-1 years<br />
Rating: MPharm, BPharm, BHMS, BNYS, MBB, M.sc (biotechnology), B.tech (Biotechnology)<br />
Location: Chennai / Bangalore<br />
Industry Type: Pharma, Biotech, clinical data analyst, CRA<br />
Last Date: April 30, 2015<br />
<br />
<b>Contact:</b><br />
HR-team<br />
91-9003448315<br />
<span style="color: blue;"><u>Email: saiclinicalrnd@gmail.com</u></span><br />
<span style="color: blue;"><u><br /></u></span>
<b>Posted By,</b><br />
Jagadish M<br />
Sai Institute of Clinical Research</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-81262338070739463242015-03-20T09:01:00.000-07:002015-03-20T09:01:59.424-07:00Banasthali Vidhyapith requires Faculty Positions Department of Pharmacy, Pharmacy, Pharmaceutical Chemistry<div dir="ltr" style="text-align: left;" trbidi="on">
Banasthali Vidhyapith requires Faculty Positions Department of Pharmacy, Pharmacy, Pharmaceutical Chemistry<br />
The origin of Banasthali is unique in more ways than one. Banasthali owes its existence nor the zeal of a teacher, nor that of a social reformer. Nor is the creation of a philanthropist bag. It has emerged as the fabled phoenix from the ashes of a flower Shanta Bai had withered before flowering. Is a spontaneous filling the void caused by Shantabai was death.It of 6 October 1935 when Smt. Ratan Shastri and Pandit Hiralal Shastri founded Banasthali to fill the void caused by the sudden death of his very talented and promising Shantabai daughter. They had high expectations that would work for the cause of women when she grew up. Love, eternal love has been the source of all thought and action, and this spirit has been the motivating force.<br />
<br />
Message: Professor, Associate Professor, Assistant Professor, Research Associate<br />
Science and Technology<br />
<br />
Pharmacy, Pharmacy, Pharmaceutical Chemistry<br />
<br />
Qualifications as per UGC / AICTE / NCTE / PCI / Bar Council of India norms and Wages in pay bands as Sixth Pay Commission recommendations. Compensation not a hurdle for competent candidates. Reservations for rules Banasthali Vidyapith. Workers must become habitual user of Khadi on appointment.<br />
Applications duly supported by testimonials and portfolio along with recent research publication with a passport size photograph should arrive within three weeks to the Secretary, Banasthali Vidyapith, Banasthali Vidyapith PO-304022 (Rajasthan).<br />
<br />
Candidates can download the prescribed application form on the website of the University.<br />
<br />
Last Date: April 6, 2015<br />
<br />
To download the application please click the link below. If you did not open copy and paste the link into your search box.<br />
<span style="color: blue;"><u>http://www.banasthali.org/banasthali/wcms/en/home/lower-menu/recruitments/TeachingApplicationForm.pdf</u></span></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-13376503959715408502015-03-16T04:02:00.000-07:002015-03-16T04:02:51.807-07:00Zoledronic acid <div dir="ltr" style="text-align: left;" trbidi="on">
<b> Zoledronic acid</b> is the drug used to treat Osteoporosis and other bone disorders especially for women. It is having several side effects like Osteonecrosis of the jaw.<br />
<br />
Recently, European union advisory board has recommended measures to minimize osteonecrosis of the jaw. Pharmacovigilance Risk assessment committee(PRAC) of Europe has advised that the patients has to remind about adverse effects of Zoledronic acid and patients has to provide leaflets about side effects of drug.<br />
<br />
PRAC also advised that patients has to provide leaflets which contain advantages of treatment with Zoledronic acid and disadvantages of treatment as osteonecrosis of jaw. It is very common side effect in menopause woman than men.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi26_fBhOUCU3FJSZYUEK4ab1Q39Gm08G_RsYO3GGWvufpDLF4M7YZJi04qA1DNy_OK8QUJ0pHNElwfyTxD56ZyOl2Di3VXNyWnd70W9AOcoPH3yOqyA6Zi4hAXQph9NTlYtiFZW4Nj1P0/s1600/download.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi26_fBhOUCU3FJSZYUEK4ab1Q39Gm08G_RsYO3GGWvufpDLF4M7YZJi04qA1DNy_OK8QUJ0pHNElwfyTxD56ZyOl2Di3VXNyWnd70W9AOcoPH3yOqyA6Zi4hAXQph9NTlYtiFZW4Nj1P0/s1600/download.jpg" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<br />
<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhsJ486TTJ93qRtd8q-uSbybYgiujXrwALdIptgaPiDKHvDic8XGsOUtSI8VbPGxzBKNS4-H_SeltTx0rXDI6DURsw9AzpdIWFJaOaTbA-zN7bcye8Ep3esx_tAY1_VuoaRuiE4-LXUaA0/s1600/download+(1).jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhsJ486TTJ93qRtd8q-uSbybYgiujXrwALdIptgaPiDKHvDic8XGsOUtSI8VbPGxzBKNS4-H_SeltTx0rXDI6DURsw9AzpdIWFJaOaTbA-zN7bcye8Ep3esx_tAY1_VuoaRuiE4-LXUaA0/s1600/download+(1).jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Osteonecrosis of Jaw</b></td></tr>
</tbody></table>
<br /></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-19284668606564085042015-03-12T08:26:00.000-07:002015-03-12T08:26:32.628-07:00Since the quality Executive Control-, INCHARGE in Tuscany International | can only request candidates with experience<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
TOSC International Pvt Ltd. is one of the leading pharmaceutical companies in India, since 1985. With two manufacturing units - Delhi and Free Zone excise Pantnagar (Rudrapur), manufacture and supply a wide therapeutic mixture of products in the form of tablets, ointments, syrups, capsules Nutraceuicals (foodstuffs), injections, eye / ear drops. The company has made progress steadily success by earning a prestigious name among pharmaceutical companies in India.<br />
<br />
<b>Message:</b> Executive-2 Control of Quality, Quality Control INCHARGE-1<br />
<br />
<b>Job Description</b><br />
<br />
Must have good knowledge of instrumental, chemical and microbiological analysis, QA / QC, WHO GMP, documentation, validation, etc.<br />
<br />
Instrumental and Microbiology FDA Applicants who are approved in Chemistry section shall be preferred.<br />
<br />
<b>Additional Information:</b><br />
Experience: 10 years<br />
Rating: B.Sc/M.Sc/B.Pharm/M.Pharm<br />
Location: Delhi<br />
Industry Type: Pharma<br />
Functional Area: Quality Control, Pharmaceutical Analysis<br />
Last DATE: 02/28/2015<br />
<br />
Where to send your CV in <span style="color: blue;"><u>hr@toscindia.com</u></span><br />
<span style="color: blue;"><u><br /></u></span>
Please Dont apply fresh candidates</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-34648808368002138712015-03-11T01:36:00.000-07:002015-03-11T01:36:09.267-07:00Opportunity for Fresh Drug Safety Associate - Pharmacovigilance in HySynth BioTechnologies | 30 Posts<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
HySynth BioTechnologies is a contract research organization based in Chennai, South India. We Provide outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries.<br />
<br />
<b>Post:</b> Drug Safety Associate - Pharmacovigilance<br />
<b>No.of post: </b>30<br />
<br />
<b>Job Description</b><br />
Technicalities in case processing Pharmacovigilance Including case triage, Causality determination coding principles.<br />
• Performed medical coding using MedDRA, Case Narrative writing, submission criteria and regulatory timeline etc. Requirements<br />
• Competent in handling and processing Responsibilities of reviewing adverse events Reported by Investigators and can perform the tasks of conducting research and analyzing medical and scientific literature required at times.<br />
• Proficient in computer Prioritizing tasks and completing computer in Accurately, and Efficiently, yet flexible to multitask When Necessary to Achieve Personal and team goals<br />
Candidate Profile<br />
Life Science, for medical, medical<br />
Ability to work within a team environment<br />
Good interpersonal skills<br />
Fresher<br />
<br />
<b>Additional Information:</b><br />
Experience: Fresher<br />
Location: Chennai<br />
Fucntional Area: Pharmacovigilance<br />
Industry: Pharma / Biotech<br />
Last Date: 31st March, 2015<br />
<b><br /></b>
<b>Posted By,</b><br />
Anil Chennupati<br />
Hysynth Bio Technologies<br />
Interested candidates send updated résumés at<span style="color: blue;"> hr_rec@hysynth.co.in</span></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-66806364335559740902015-03-09T01:16:00.001-07:002015-03-09T01:16:08.869-07:00Central Council for Research in Siddha invites B.Pharm, M.Pharm Assistant Research Officer, Research Assistant, Pharmacist, Lab Technician, Lab Assistant<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The Central Council for Research in Siddha, a dependent of the Ministry of AYUSH autonomous agency, invites applications from suitable candidates for the following positions of group B and C to be filled by Direct Recruitment. We advise candidates to read the instructions available on the Council website before completing the application. The upper age limit, qualifications and / or experience will be counted as 01/01/2015.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Message:</b> Research Assistant, Research Assistant, Pharmacist, Lab Technician, Lab Assistant</div>
<div style="text-align: justify;">
<span style="color: blue;"><br /></span></div>
<div style="text-align: justify;">
<span style="color: blue;">Advertisement No. 02/2015</span></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Research Assistant (Botany / Pharmacognosy)</b></div>
<div style="text-align: justify;">
Pay Scale: (PB2) Rs 9300-34800 + GP Rs.4600</div>
<div style="text-align: justify;">
Number of Vacancies: 4 (UR -4)</div>
<div style="text-align: justify;">
Age: 35 years and below</div>
<div style="text-align: justify;">
Education and other qualifications: Essential: (a) Post-graduate degree in Botany / Pharmacognosy, University / Institution (b) three years of experience in research / teaching recognized in Botany / Pharmacognosy after obtaining Degree (10 + 2 + 3 patterns) in a Ph.D recognized Institution / College / University (OR) in Botany / Pharmacognosy, University / recognized institution.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Research Assistant (Chemistry)</b></div>
<div style="text-align: justify;">
Pay Scale: (PB2) Rs 9300-34800 + GP Rs.4600</div>
<div style="text-align: justify;">
Number of vacancies: 2 (UR-2)</div>
<div style="text-align: justify;">
Age: 35 years and below</div>
<div style="text-align: justify;">
Education and other qualifications: Essential: (a) Post-graduate in Chemistry for / Institution (b) three years of research experience / education recognized University of Chemical after obtaining Degree (10 + 2 + 3 pattern) a recognized Institution / College / University (OR) PhD in Chemistry from the University / Institution recognized.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Research Assistant (Botany)</b></div>
<div style="text-align: justify;">
Pay Scale: (PB2) Rs 9300-34800 + GP Rs.4200</div>
<div style="text-align: justify;">
Number of Vacancies: 4 (UR -4)</div>
<div style="text-align: justify;">
Age: 30 years and below</div>
<div style="text-align: justify;">
Educational and other qualifications: Essential: a) Degree (10 + 2 + 3 pattern) in Botany from the University / Institution recognized. b) Two years of research experience / education in Botany after obtaining the degree (10 + 2 + 3 pattern) in an institution / college / recognized university. (OR) Degree in Botany from the University / Institution recognized</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Research Assistant (Chemistry)</b></div>
<div style="text-align: justify;">
Pay Scale: (PB2) Rs 9300-34800 + GP Rs.4200</div>
<div style="text-align: justify;">
Number of Vacancies: 4 (UR -3, SC-1)</div>
<div style="text-align: justify;">
Age: 30 years and below</div>
<div style="text-align: justify;">
Education and other qualifications: Essential: a) Degree (10 + 2 + 3 pattern) in Chemistry from a recognized University / Institution b) Two years experience of research / teaching chemistry after obtaining the degree (10 + Wizard Research (Pharmacology)</div>
<div style="text-align: justify;">
Pay Scale: (PB2) Rs 9300-34800 + GP Rs.4200</div>
<div style="text-align: justify;">
Number of Vacancies: 1 (UR-1)</div>
<div style="text-align: justify;">
Age: 30 years and below</div>
<div style="text-align: justify;">
Educational and other qualifications: Essential: BVSc / B.Pharm / M.Sc in pharmacology Assay / Drug college / recognized institution.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Advertisement No. 03/20152 + 3 patterns) in a / College / University recognized institution (OR) Degree in Chemistry from the University / Institution recognized</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<span style="color: blue;">Advertisement No. 03/2015</span></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Pharmacist</b></div>
<div style="text-align: justify;">
Pay Scale: (PB1) Rs 5200-20200 + GP Rs.2800</div>
<div style="text-align: justify;">
Number of vacancies: 2 (UR-1, OBC-1)</div>
<div style="text-align: justify;">
Age: 25 years and under</div>
<div style="text-align: justify;">
Education and other qualifications: Essential: (a) Matric or equivalent (b) Certificate / Diploma in Pharmacy Siddha minimum of two years from a statutory Board / University / Institution (c) recognized two years experience preferably in the clinic / Hospital Medicine Siddha or a recognized pharmacy.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Lab Technician</b></div>
<div style="text-align: justify;">
Pay Scale: (PB1) Rs 5200-20200 + GP Rs.2400</div>
<div style="text-align: justify;">
Number of places: 11 (UR -7, SC-2, ST-2)</div>
<div style="text-align: justify;">
Age: 25 years and under</div>
<div style="text-align: justify;">
Educational and other qualifications: Essential: (a) Degree (10 + 2 + 3 pattern) in science, in the discipline in question (Chemistry / Biochemistry / MLT / Botany) / B.Pharm degree in pharmacology or a university recognized (b) One year of experience in laboratory technology in a laboratory of a hospital / recognized institution (OR) (a) 12 (10 + 2) Class or equivalent with Science subject from a Board / University (b) Diploma recognized Medical Laboratory Technology minimal yearlong from a recognized University / Institution (c) Two years experience in a laboratory recognized Hospital / Institution.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Laboratory assistant</b></div>
<div style="text-align: justify;">
Pay Scale: (PB1) Rs 5200-20200 + GP Rs.2000</div>
<div style="text-align: justify;">
Number of vacancies: 3 (UR -3)</div>
<div style="text-align: justify;">
Age: 25 years and under</div>
<div style="text-align: justify;">
Education and other qualifications: Essential: (a) 12 (10 + 2) Class or equivalent with Science subject from a Board / University (b) Two years experience in a laboratory recognized hospital / recognized institution (OR) Grade (10 + 2 + 3 pattern) {Sciences (Chemistry / Botany) / BSc in pharmacology or B Pharm)</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Candidates will be selected on the basis of the written test followed by an interview. The date for the written / interview test will be displayed on the website of the Council and of the call letter will be mailed speed. The deadline for receipt of application is 60 days from the date of publication of this advertisement in the Employment News.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Instructions and guidance to applicants:</b></div>
<div style="text-align: justify;">
<b><br /></b></div>
<div style="text-align: justify;">
It encourages applicants to carefully read all the instructions before completing their applications.</div>
<div style="text-align: justify;">
1. The applicant must be a citizen of India.</div>
<div style="text-align: justify;">
2. All applicants must meet the essential requirements and other conditions set forth in the notice. You are advised to make sure before applying to have established essential criteria for various posts. No petition asking for advice regarding eligibility will be entertained.</div>
<div style="text-align: justify;">
3. The essential criterion is the minimum prescribed mere possession of the same does not entitle candidates to be called for written / interview test. The competent authority reserves the right to shortlist candidates on the basis of qualifications / year of experience in the subject / other higher criteria. The decision of the Director General, CCRS be final in this regard.</div>
<div style="text-align: justify;">
4. The period of experience dictated by a candidate on part time basis, the daily wage, visitors / customers teachers will not be counted when calculating the valid experience.</div>
<div style="text-align: justify;">
5. The maximum age limit, qualifications and / or experience will be computed as in 01/01/2015</div>
<div style="text-align: justify;">
6. Candidates must have passed the qualifying examination and 01/01/2015. Candidates who have come forward to the qualifying examination but whose results have not been declared by the crucial date are not eligible.</div>
<div style="text-align: justify;">
7. Degree / Diploma etc. obtained by candidates from open / Education Universities Distance will not be accepted unless it is accompanied by a certificate to the effect that the course is recognized by the Council for Distance Education in terms of Ministry of Human Resource Development Notification No. 44 published in the Gazette of India dated 04/08/1995 by the relevant period when the candidate has acquired the relevant qualification.</div>
<div style="text-align: justify;">
8. Candidates serving in Govt. / Autonomous / statutory bodies should only apply through proper channel and duly submitted application should reach the Central Council for Research in Siddha on or before the closing date. Must submit certificate of "no objection" from his employer at the time of the interview. In case you do not provide it, your application will be immediately rejected.</div>
<div style="text-align: justify;">
9. Candidates applying for more than one post must submit separate application for each post, along with application fee request. One envelope should contain a single application form. More than one application in one envelope lead to rejection of all these applications. Similarly, more than one application for the same candidate for the same consideration also leads to the rejection of all applications.</div>
<div style="text-align: justify;">
10. The vacancies advertised are provisional and may vary. This is subject to change without notice. If the vacant position is indicated in advertising comes down to any number or even zero, the Council is not obliged to compensate the applicant for any consequential damage / loss.</div>
<div style="text-align: justify;">
11. DG, CCRS reserves the right to make any modification, cancellation and changes on this page, in whole or in part without assigning any reason thereof.</div>
<div style="text-align: justify;">
12. Any error correction / order regarding this advertisement is generated only at the website. We advise candidates to stay in touch with the website for this purpose. No separate error correction etc. will be published in News Jobs or any other newspaper.</div>
<div style="text-align: justify;">
13. Applicants will be fully responsible for the accuracy of the information provided. All information provided by the candidate, if you feel unwell at any stage, will lead to his / her disqualification and / or dismissal from the service at any time and no correspondence will be entertained at all.</div>
<div style="text-align: justify;">
14. The letter of invitation to the written / interview if shortlisted candidates will be mailed test speed, so that candidates must attach to your 39 / -R. seal affixed in size 26x11 cm. However, the Council will not be responsible for any postal / span delay at all. The date of the written test / interview will be shown on the website of the Council.</div>
<div style="text-align: justify;">
15. Appointment to this position will be subject to medical fitness certificate of candidate issued by the Authority Medical Board / Medical competent before joining the post.</div>
<div style="text-align: justify;">
16. The applicant will have to appear for written test / interview, if asked, in his / her own expense.</div>
<div style="text-align: justify;">
17. The appointment carries with it the responsibility to serve anywhere in India</div>
<div style="text-align: justify;">
Will be admitted 18. No correspondence or personal consultations will continue.</div>
<div style="text-align: justify;">
19. Canvassing in any form will be treated as a disqualification for the post.</div>
<div style="text-align: justify;">
20. Any dispute regarding this contract shall be subject to courts / tribunals with jurisdiction in Chennai.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Number of vacancies for all positions may vary depending on the need of advice</div>
<div style="text-align: justify;">
Full details and application form can be downloaded from the website of the Council.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<span style="color: blue;">www.siddhacouncil.com / www.siddharesearchcouncii.org</span></div>
<div style="text-align: justify;">
<span style="color: blue;"><br /></span></div>
<div style="text-align: justify;">
<b>Last date: </b>60 days after publication </div>
<div style="text-align: justify;">
<b>Last Date:</b> May 7, 2015</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>To apply online:</b></div>
<div style="text-align: justify;">
Click the link below or copy and paste search box and download the application form</div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-85770054813505738772015-03-08T03:51:00.000-07:002015-03-08T03:51:32.341-07:00Statins-Contraindicated for type 2 Diabetes<div dir="ltr" style="text-align: left;" trbidi="on">
<b>Statins:</b><br />
<b><br /></b>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> Statins</span><span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> (or </span><span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">HMG-CoA reductase inhibitors</span><span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">) are a class of </span>drugs<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> used to lower </span>cholesterol<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> levels by </span>inhibiting<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> the enzyme </span>HMG-CoA reductase<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">, which plays a central role in the production of cholesterol in the </span>liver<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">, which produces about 70 percent of total cholesterol in the body. High cholesterol levels have been associated with </span>cardiovascular disease<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> (CVD).</span><span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> Statins have been found to </span>prevent<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> cardiovascular disease and mortality in those who are at high risk. The evidence is strong that statins are effective for treating CVD in the early stages of a disease (</span>secondary prevention<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">) and in those at elevated risk but without CVD (</span>primary prevention<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">).</span><span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> Side effects of statins include </span>muscle pain<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">, increased risk of </span>diabetes mellitus<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"> and abnormalities in </span>liver enzyme tests<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">.</span><span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 11px; line-height: 11px;"> </span><span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">Additionally, they have rare but severe adverse effects, particularly muscle damage.</span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"><b>Eg:</b></span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">1. Fluvastatin</span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">2. Rosuvastatin</span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">3. Simvastatin etc.,</span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"><br /></span></div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEifvdEKl1R-4Hlp4aXeJ_tnt2JaZHFlbIBkgRPDKZzGcsBllsXI1DxbwPItYtyRVfsrviiuI9MqjH08JS3ruPR6O__2guX0Io8DabTfyw2qeFswyjcjPph2E9xRX0BIYxrIn3lJzLtpaag/s1600/image_update_ed743298872bf984_1337236099_9j-4aaqsk.jpeg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEifvdEKl1R-4Hlp4aXeJ_tnt2JaZHFlbIBkgRPDKZzGcsBllsXI1DxbwPItYtyRVfsrviiuI9MqjH08JS3ruPR6O__2guX0Io8DabTfyw2qeFswyjcjPph2E9xRX0BIYxrIn3lJzLtpaag/s1600/image_update_ed743298872bf984_1337236099_9j-4aaqsk.jpeg" height="179" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Statins</b></td></tr>
</tbody></table>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"><br /></span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"><b>Type II D.M:</b></span></div>
<div style="text-align: justify;">
<span style="color: #252525; font-family: sans-serif;"><span style="background-color: white;"><span style="font-size: 14px; line-height: 22.3999996185303px;">Type II DM is the disease in which insulin deficiency occurs though insulin production is normal but the uptake of insulin by tissues may disturbs leads to imbalanced blood sugar levels. This disorder will be treated with oral hypoglycemics. </span></span></span></div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjsB8IJzAuK5lZru9PxnI9OtR5dfU_-q5hOIstXv8wQ_0iqNs91prqAY5uFlJG-uaanjNa2_6nVatMJkY8i35TfnCzqto9iz0RHNrVslFktVp60vbJqso0s0AT3RhbA41UpDpx_Ths8M_s/s1600/images.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto; text-align: center;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjsB8IJzAuK5lZru9PxnI9OtR5dfU_-q5hOIstXv8wQ_0iqNs91prqAY5uFlJG-uaanjNa2_6nVatMJkY8i35TfnCzqto9iz0RHNrVslFktVp60vbJqso0s0AT3RhbA41UpDpx_Ths8M_s/s1600/images.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Diabetes Mellitus</b></td></tr>
</tbody></table>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"><b><br /></b></span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;"><b>Statins are contraindicated for Type II DM patients:</b></span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #252525; font-family: sans-serif; font-size: 14px; line-height: 22.3999996185303px;">Recent studies telling that usage of statins (HMG-Co A Reductase inhibitors) in CVD patients who have the</span><span style="background-color: white;"><span style="color: #252525; font-family: sans-serif;"><span style="font-size: 14px; line-height: 22.3999996185303px;"> history of Type II DM may leads to several health disasters as sudden death and sometimes leads to severe heart diseases. So while using statins in Type II DM must be conscious about cardiac diseases.We have to strictly monitor the cardiac markers and all other biological markers to avoid severe heart conditions which are sometimes fatal.</span></span></span></div>
<div style="text-align: justify;">
<span style="background-color: white;"><span style="color: #252525; font-family: sans-serif;"><span style="font-size: 14px; line-height: 22.3999996185303px;"><br /></span></span></span></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div style="text-align: justify;">
<span style="background-color: white;"><span style="color: #252525; font-family: sans-serif;"><span style="font-size: 14px; line-height: 22.3999996185303px;"><br /></span></span></span></div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-19696283936378198722015-02-25T06:59:00.002-08:002015-03-06T07:10:24.126-08:00New hidden features of IOS 8<div dir="ltr" style="text-align: left;" trbidi="on">
Our collection of hidden and undocumented features found in iOS 8, which was released on September 17 See our iOS 8 Summary of official functions.<br />
<br />
<b>FEATURES INCLUDE</b><br />
Credit Card Scanning Safari<br />
Using the stack App<br />
Wi-Fi Calling<br />
Camera Mode Time-Lapse<br />
Hide Pictures in Photos App<br />
<br />
If our greatest asset in August raid IOS focuses on major changes announced by Apple, this iOS 8 raid highlights some of the most interesting new features and improvements, but less mobile operating system from Apple around the beta testing period.<br />
<br />
Apple released iOS 8 to the public on September 17, 2014, two days before the launch of iPhone 6 and 6 Plus. Before the public launch, the software went through five betas to developers before a master of gold was released on September 9.<br />
<br />
The current version of iOS 8 is iOS 8.1.3, a minor update released on January 27 with several bug fixes and performance improvements. Before iOS 8.1.3, Apple released iOS 8.1 with new features like SMS payment Apple and transfer calls. Apple has seeded iOS 8.2 beta for multiple developers, the SDK WatchKit and some other bug fixes. iOS 8.2 could be released in March. iOS 8.3, which adds features like wireless CarPlay and a new emoji selector is also in development.</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-62055826842905889322015-02-24T02:09:00.001-08:002015-03-06T07:11:29.279-08:00Panobinostat - Get Approval by FDA for the treatment of Relapsed Multiple Myeloma<div dir="ltr" style="text-align: left;" trbidi="on">
The US FDA recently gave approval for Panobinostat for the treatment of Relapsed Multiple Myeloma. Previously in 2014 it was rejected by FDA Oncologic Drugs Advisory Committee due to its adverse effects. After rejection the manufacturers again submitted additional information to FDA about drug.<br />
<br />
By studying all the information FDA approves Panobinostat. It is approved to use along with bortezomib and dexamethasone. It is effective in the treatment of Relapsed multiple myeloma in patients who received bortezomab for past 2 years. It is the new class of agents that acts as histone deacetylase inhibitor.<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhFCw3kajUTV9ZlzCVCqivT1oTmfKqLrctDPBHjpa0ofheoCypg6m9nIGdWf9Xy7YFSzp2Iof5dMCDSfSJvAJobMGwjbDHQW7kpgLGa7HURSBLV22HZVj0f4tSt_yfVMmBIfCoUfzbr0l4/s1600/download.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhFCw3kajUTV9ZlzCVCqivT1oTmfKqLrctDPBHjpa0ofheoCypg6m9nIGdWf9Xy7YFSzp2Iof5dMCDSfSJvAJobMGwjbDHQW7kpgLGa7HURSBLV22HZVj0f4tSt_yfVMmBIfCoUfzbr0l4/s1600/download.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Mechanism of Action of Panobinostat</td></tr>
</tbody></table>
<br />
<br />
It is having new mechanism of action than other cancer agents as histone deacetylase inhibition makes this drug attractive among other cancer drugs. The safety and efficacy data of Panobinostat is based on the clinical study on 193 patients who had received prior treatment with bortezomib and immuno modulatory agents. The clinical phase used is phase 3, randomized,double blind,placebo controlled, multicenter global registration trail. This drug is having several adverse effects which make it rejection by FDA previously.<br />
<br />
Adverse effects:<br />
The common adverse effects are,<br />
1. Nausea<br />
2. Vomiting<br />
3. Diarrhoea and<br />
4. Fatigue.<br />
<br />
The most common side effects of this drug in clinical trails are diarrhea, fatigue, nausea, peripheral edema, decreased appetite, pyrexia, and vomiting, with the most common nonhematologic laboratory abnormalities.<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhXt-t1vd-HFX_-8Laay2IEOwmjqwTwVTqoTH9S7bBQ5CxUK8bCQKZNxun_k-Cp4xrVceHG3kMQubYDThMOlTMCGXklU-CmejQjYMh0Bpd2myKLohJMbR9a2Iz9uJl5x0f31P2i_GP9BaI/s1600/Pills+Various+Colors+2.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhXt-t1vd-HFX_-8Laay2IEOwmjqwTwVTqoTH9S7bBQ5CxUK8bCQKZNxun_k-Cp4xrVceHG3kMQubYDThMOlTMCGXklU-CmejQjYMh0Bpd2myKLohJMbR9a2Iz9uJl5x0f31P2i_GP9BaI/s1600/Pills+Various+Colors+2.jpg" height="194" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Panobinostat capsules</td></tr>
</tbody></table>
<br />
<br />
Common hematologic abnormalities include thrombocytopenia, lymphopenia, leukopenia,neutropenia and anemia. The serious side effect include cardiac toxicity and severe diarrhoea.<br />
<br />
So, the patients who receiving panobinostat had to monitor for the adverse effects especially for anemia.</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-37290380868440916702015-02-15T06:41:00.002-08:002015-03-06T07:15:10.589-08:00Ovarian cancer risk may increased by Hormone Replacement Therapy <div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
</div>
<div style="text-align: justify;">
At menopause stage the women bodies stop producing sex hormones (estrogen,progesterone) which are important to maintain normal physiological functions like metabolism,mental activities etc., So after menopause (at post menopausal stage) woman starts to take Estrogen and progesterone pills under the super vision of gynecologist. This is called as Hormone Replacement Therapy (HRT) .</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
HRT therapy having some side effects. These are common and mild in nature like dizziness,weight gain,mood swings etc., Recent studies reveal that long term use of HRT may increase the risk of ovarian cancer. The researchers conducted epidemiological studies at U.S by using case and control group and concluded that HRT may increases cancer risk.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
It is very severe in the patients in whom ovaries are dissected at the time of hysterectomy. But risk is lesser in patients with ovaries. The researchers conduct case control study in which, </div>
<div style="text-align: justify;">
1.case group is Patients are post menopausal and having ovarian cancer</div>
<div style="text-align: justify;">
2. Control group is patients are postmenopausal but not having ovarian cancer and still having their ovaries.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
They compare both groups by conducting meta-analysis and concluded that the usage of HRT for even less period may increases the cancer risk up to 20% . The researchers also told that patient related factors like body weight,hysterectomy, other diseases does not shows effect on HRT. The more the recent the therapy the great the risk. Woman who had stopped HRT recently but were within 5 years of last use at the time of their cancer risk , although having used HRT for at least 5 years was still associated with 10% increased relative risk more than 5 years later.<br />
<br />
<b>Ways to avoid Adverse effects of HRT :</b><br />
There are some ways to relief from the side effects of HRT. If we follow these we can get rid of side effects. They are, <br />
1. Yoga<br />
2. Aerobics<br />
3. Healthy food<br />
4. Daily exercises<br />
5. Meditation etc.,</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj5zohxSBQdpp_RoEyPHgK6xXu4Z1Z1Oz5RcsFhzJEfSBnFdqCZ036Ez0fdArZWCw6QBEWaD9_2S0-HL0QcuqwFIZRNr8Pu4AahI7IX0J5h94vaTvXVdWlO0Htmgq_cvnwovdda3mX2Wes/s1600/article-0-05B6AF6B000005DC-710_468x286.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj5zohxSBQdpp_RoEyPHgK6xXu4Z1Z1Oz5RcsFhzJEfSBnFdqCZ036Ez0fdArZWCw6QBEWaD9_2S0-HL0QcuqwFIZRNr8Pu4AahI7IX0J5h94vaTvXVdWlO0Htmgq_cvnwovdda3mX2Wes/s1600/article-0-05B6AF6B000005DC-710_468x286.jpg" height="195" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>HRT Pill</b><br />
<br />
<br />
<b></b>
<b><br /></b></td></tr>
</tbody></table>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
</div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-84845158308893318602015-02-06T23:45:00.002-08:002015-03-06T07:16:29.518-08:00New FDA Clearance for Ranibizumab for Diabetic Retinopathy with DME<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
</div>
<div style="text-align: justify;">
The USFDA has expanded sate use of Ranibizumab for diabetic retinopathy ane Diabetic Macular Edema (DME) treatment. Diabetes is one of the deadly disease that affecting millions of people every year world wide. In this disease the sugar levels of blood will changes time to time with our order. The patient looses body sugars in urine which makes fall down of sugar levels.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
At the time of eating body sugar levels will increases suddenly which damages body organs. Diabetic patients are more prone to organ damages. The main organ is eye. Several diabetic patients are suffering with diabetic retinopathy which impairs vision. So it needs proper treatment. Organ failure chances will increase with age. It is the most common diabetic eye disease and is leading cause of blindness in adults in US.</div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgzn1Y5TJ0oWdI5-pHPQFfxmw8uVPK_hLha9EUjtT4sXqQahvodoSsVM_m1TkgOc4fYdnEJjjOnwYQz1ZipiUL7mOhqiZtFGOUXfB5MiYH9oaeJuV76waY-mLbjObcZOW0bSAe47bk3UwQ/s1600/Fundus_photo_showing_scatter_laser_surgery_for_diabetic_retinopathy_EDA09.JPG" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgzn1Y5TJ0oWdI5-pHPQFfxmw8uVPK_hLha9EUjtT4sXqQahvodoSsVM_m1TkgOc4fYdnEJjjOnwYQz1ZipiUL7mOhqiZtFGOUXfB5MiYH9oaeJuV76waY-mLbjObcZOW0bSAe47bk3UwQ/s1600/Fundus_photo_showing_scatter_laser_surgery_for_diabetic_retinopathy_EDA09.JPG" height="201" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Diabetic retinopathy</b></td></tr>
</tbody></table>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
</div>
<div style="text-align: justify;">
The present drug Ranibizumab is the first significant therapy to treat diabetic retinopathy and diabetic macular edema.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Safety and Efficacy studies of Ranibizumab:</b></div>
<div style="text-align: justify;">
This profile is obtained by 2 clinical studies involving 759 participants who were treaed and followed for 3 years. In the two studies, treatment with Ranibizumabled to significant improvement in severity of DME and diabetic retinopathy when compared with the patients who does not receiving the drug.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Side effects:</b></div>
<div style="text-align: justify;">
1. Bleeding of conjuctiva</div>
<div style="text-align: justify;">
2. Eye pain</div>
<div style="text-align: justify;">
3. Floaters</div>
<div style="text-align: justify;">
4. Increased IOP(Intra Occular Pressure)</div>
<div style="text-align: justify;">
5. Endophthalmitis and retinal detatchment (Serious)</div>
<div style="text-align: justify;">
<br /></div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><img src="data:image/jpeg;base64,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" style="margin-left: auto; margin-right: auto;" /></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Ranibizumab</b></td></tr>
</tbody></table>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Previously FDA had approved ranibizumab to treat DME and macular edema secondary to retinal vein occlusions, both of which cause fluid to leak into the macula result in blurred vision. Recently FDA granted the Ranibizumab for diabetic retinopathy with DME and reviewed this new use for the drug under the agency's priority review program, which provides for an expedited review of drugs. This drug provides safe and effective treatment in serious condition.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Route of administration:</b></div>
<div style="text-align: justify;">
Ranibizumab is administered by IV injection once monthly.</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg5WqpvI-JXzB4RQqRXp02uf3S56ak32k64O__Z0mq-aJKb4eyYLNgDtxT_SJU9QH-o1H-r48DAwF4E0qEMfuE6oqhiITW4HIPapziqHgZ6P_OWDpERUxq40VcKHMYv9Qy2hhUHfprJ1CI/s1600/download.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg5WqpvI-JXzB4RQqRXp02uf3S56ak32k64O__Z0mq-aJKb4eyYLNgDtxT_SJU9QH-o1H-r48DAwF4E0qEMfuE6oqhiITW4HIPapziqHgZ6P_OWDpERUxq40VcKHMYv9Qy2hhUHfprJ1CI/s1600/download.jpg" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Other uses of Ranibizumab:</b></div>
<div style="text-align: justify;">
It is also approved for the treatment of neovascular (wet) age related macular degeneratin in US.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
</div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-70220145251757712302015-01-21T07:24:00.000-08:002015-03-06T07:17:28.723-08:00CAN WE PREVENT CANCER DEATHS.....BY THE YEAR 2050??? <div dir="ltr" style="text-align: left;" trbidi="on">
Yes, obviously.....<br />
The recent studies conducted in U.K telling that cancer deaths can be prevented in the age group of below 80 years by the year of 2050. Cancer occurrence at younger stage and adult age below 80 tears can be cured by using present treatment methods.<br />
<br />
<b>How can we??</b><br />
This is the question that everyone will ask after hearing this news. Here, is the answer. As we know that the main problem in the treatment of cancer is, delay in the detection. Cancer symptoms are not at all detectable at the early stages. In some persons a few symptoms may be detectable. Because the symptoms of cancer are same as other common diseases.<br />
<br />
<b>How to detect cancer at early stages:</b><br />
To detect cancer at early stages we need some knowledge.<br />
1. Every person has to aware about cancer symptoms.<br />
2. Government and other professionals have to take step forward to educate people about symptoms.<br />
3. Encourage people to consult physician when suspicious cancer symptoms are detected.<br />
<br />
<b>Main cancers that causing more deaths:</b><br />
There are some cancers in the modern society that causes more deaths. They are<br />
1. Ovarian cancer<br />
2. Breast cancer <br />
3. Prostate cancer<br />
4. Oral cancer<br />
5. Colon cancer<br />
These are some of the main cancer that are causing deaths. So the society has to conscious about the symptoms of these types of cancers. <br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><img alt="Illustration Of Ovarian Cancer" class="slide_image" src="http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/health_tools/ovarian_cancer_overview_slideshow/getty_rm_photo_of_ovarian_cancer_collage.jpg" height="217" id="slide_image1" name="slide_image1" style="margin-left: auto; margin-right: auto;" width="320" /></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Ovarian cancer</b></td></tr>
</tbody></table>
<br />
<br />
<b>Preventive Measures:</b><br />
Everyone is thinking that cancer is the deadly disease and if cancer occurs there is no way for anything that death. First we have to erase this belief from minds. Several people scare to consult physician with cancer symptoms by expecting the diagnostic outcome. So, we have to encourage to consulting physician.<br />
<br />
It is not easy to prevent cancer without proper steps. Here are some of them.<br />
1. Follow healthy life style.<br />
2. Early detection of disease.<br />
3. Advanced diagnostic techniques<br />
4. Advanced treatment methods<br />
5. Healthy food habits<br />
6. Medication adherence<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><img class="irc_mut" height="199" src="https://encrypted-tbn2.gstatic.com/images?q=tbn:ANd9GcQ5Up5C9snpvF02hE05zmXpx-IXODUN2sZLZ0r8YMGX-dw906vx_g" style="margin-left: auto; margin-right: auto; margin-top: 0px;" width="320" /></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Healthy food</b></td></tr>
</tbody></table>
<br /></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-33257432645232647942015-01-18T07:11:00.000-08:002015-03-06T07:18:27.052-08:00NEW OBESITY TREATMENT GUIDELINES ACCORDING TO AHA<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
Obesity is one of the major cause of several diseases now a days. The obesity cases are increasing gradually day by day in modern society. A new endocrine Society Clinical-practice guideline on the pharmacological management of obesity outlines a plan for the use of weight loss medications and get away from the medication which are associated with weight gain.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Professionals who involved in the present research warns the health care professionals that, they must treat the obesity first before going to treat other comorbidities caused by weight gain like,</div>
<div style="text-align: justify;">
1. Diabetes</div>
<div style="text-align: justify;">
2. Hypertension and</div>
<div style="text-align: justify;">
3. Dislipidamia.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Drugs available for the treatment of Obesity:</b></div>
<div style="text-align: justify;">
1. Buprapion/Naltroxone</div>
<div style="text-align: justify;">
2. Liraglutide</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
These agents join with controlled-release Phentermine, Topiramate and Lorcaserine to treat obesity. Orlistat is available as over the counter drug in the U.S market.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Use of approved medication weight-loss medications is used for the people with a BMI of 30 kg/m2 or atleast 27 kg/m2 with or 1 or more comorbidities.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Pharmacological treatment of obesity is bariatric surgery and usage of approved weight loss medication. But the bariatric surgery involves more complications than medication. Where as</div>
<div style="text-align: justify;">
the weight loss medication usage are convinced by several patients.</div>
<div style="text-align: justify;">
<br /></div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgpPKXo1Rl4a5dCveYM6OSucZVs14nYNORK0OGiMB-BStBWjCcvhDiXmjGljbIepTZbdoxxQ2UiS8YwFgT-T-yfqnZjyYXRQlUFTNgDGEjTFlf06tuY8jbJYzlgIzpa0jo3FLpOHFlp1I0/s1600/images+(1).jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgpPKXo1Rl4a5dCveYM6OSucZVs14nYNORK0OGiMB-BStBWjCcvhDiXmjGljbIepTZbdoxxQ2UiS8YwFgT-T-yfqnZjyYXRQlUFTNgDGEjTFlf06tuY8jbJYzlgIzpa0jo3FLpOHFlp1I0/s1600/images+(1).jpg" height="238" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Change your food Hbits</b></td></tr>
</tbody></table>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The researchers also telling that the doctors has to treat obesity first and also recommend life style modifications like Yoga, Aerobics etc., Hypoglycemic agents like Metformin and other drugs can increases body weight. So the doctors has to be cautious about this medication.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<table cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: left;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYgrl9CIDvmx2K4lRCS2X2GkoAKpvekm5AgN6JoaSbReyz4nuFhAreJEv79ROyFFDqZNDH_yrRoXZ_WjdOE4pUVipnbByM5_c40Wx1-0M9u08sR7RC5Ofw6f5CfAl1mjwl_yJsssrxwQs/s1600/images.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYgrl9CIDvmx2K4lRCS2X2GkoAKpvekm5AgN6JoaSbReyz4nuFhAreJEv79ROyFFDqZNDH_yrRoXZ_WjdOE4pUVipnbByM5_c40Wx1-0M9u08sR7RC5Ofw6f5CfAl1mjwl_yJsssrxwQs/s1600/images.jpg" height="212" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Obesity</b><br />
<br />
<div style="text-align: left;">
<span style="font-size: small; text-align: justify;"><b> </b>If there is no change in weight even after the 2 weeks of therapy with any weight loss medication then immediately stop that agent and skip for other medication.</span></div>
</td></tr>
</tbody></table>
<div style="text-align: left;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-63569301306514405202015-01-16T23:12:00.000-08:002015-03-06T07:19:17.519-08:00NSAIDs protects from skin cancer<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
</div>
<b>What are NSAIDs:</b><br />
Non Steroidal anti Inflammatory Drugs are the agents which are having 3 types of activities<br />
a. Anti pyretic<br />
b. Anti inflammatory and<br />
c. Anti analgesic activity<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgh5bOvdaA8lmcSo6Aeu1cLgeqTPcQEWw7JWdNSwcVGNuKvkR9MY4hjBbMv2X2JtP58AXDq8iGaCxyN3eDqcogBBiD6D91yOD4wYgZIqWy0lfwDAr7Jp_bl3_xtzNwOvEZgvVcP0qom79o/s1600/index.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgh5bOvdaA8lmcSo6Aeu1cLgeqTPcQEWw7JWdNSwcVGNuKvkR9MY4hjBbMv2X2JtP58AXDq8iGaCxyN3eDqcogBBiD6D91yOD4wYgZIqWy0lfwDAr7Jp_bl3_xtzNwOvEZgvVcP0qom79o/s1600/index.jpg" height="320" width="248" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Non aspirin NSAIDs (Ibuprofen)</b></td></tr>
</tbody></table>
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi6rwvnA1XcGLkvv27sIDVifo7cezcJcsj8A35aLztYBQbMg5IxOXfNLlfoJZ7zYEfOJ_aNp9IKIZJMAlSo7pjckNaLYMy9SgW31aK5Dacr4xSFQfTNF1OwEHU2Xu3ZT4WQk6HE3nFhn1I/s1600/Regular_strength_enteric_coated_aspirin_tablets.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi6rwvnA1XcGLkvv27sIDVifo7cezcJcsj8A35aLztYBQbMg5IxOXfNLlfoJZ7zYEfOJ_aNp9IKIZJMAlSo7pjckNaLYMy9SgW31aK5Dacr4xSFQfTNF1OwEHU2Xu3ZT4WQk6HE3nFhn1I/s1600/Regular_strength_enteric_coated_aspirin_tablets.jpg" height="213" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Aspirin tablets</b></td></tr>
</tbody></table>
<br />
<br />
<br />
<br />
<b>Significance of NSAIDs:</b><br />
1. Used for body aches<br />
2. Used for hyperthermia (Fever)<br />
3. At inflammatory conditions<br />
4. NSAIDs are the choice of drug for arthritis and gout.<br />
<br />
<b>Side effects of NSAIDs:</b><br />
1. Hepatic failure at higher doses for a longer period of time<br />
2. Gastric irritation, gastric bleeding<br />
<br />
<b>Contraindications of NSAIDs:</b><br />
1. NSAIDs are contraindicated for renal impaired patients because NSAIDs are excreted through renal route.<br />
2. NSAIDs are contraindicated for hepatic impaired patients because it is metabolized by glucuronidyl pathway of liver.<br />
3. Contraindicated for gastritis patient as NSAIDs causes gastric bleeding. <br />
<br />
Recently it is proved that usage of NSAIDs may protect from skin cancer. <br />
It is already proven that the persons who are using NSAIDs for various health disorders are protective against several cancers like,<br />
1. Prostate cancer<br />
2. Colon cancer<br />
3. Breast cancer and<br />
4. Lung cancer<br />
<br />
Now it is evident that NSAIDs also protects from Squamous Cell Carcinoma (SCC), one type of skin cancer. NSAIDs like Aspirin and Non Aspirin usage protects from SSC AND other cancers. <br />
<br />
<b>Mechanism by which NSAIDs protects from SSC:</b><br />
NSAIDs inhibits Cyclooxigenase (COX-2) enzyme and inhibits prostaglandins (PG's) which are the mediators of inflammation. So, they inhibit the formation of tumors. By this they protects from SCC. But NSAIDs will not protective against all types of cancers but can protect from some types of tumors as we discuss above. </div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-27507205282128880282015-01-16T22:57:00.003-08:002015-03-06T07:20:16.904-08:00CELL PHONES DID NOT CAUSE BRAIN CANCER (Brain Tumor)<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
This is the new research that counters the earlier evidences which told that usage of mobile and cordless phones causes cancer. Several researchers told that cell phone usage causes health disorders like skin cancers, brain tumors. <br />
</div>
<div style="text-align: justify;">
One research that conducted in U.S told that it causes "Gliomas", type of brain tumor. To counteract this one other group of researchers starts study on people who are frequently using mobiles. It is not easy to conduct Randomized control trail. Because RCT needs to follow group of patients to a certain period of time and also it needs large test population. <br />
</div>
<div style="text-align: justify;">
It is also very expensive to conduct. So they conduct case control and cohort study on 1,00,000 people over 10 years. They conduct study in 5 countries all over the world. They observe that the incidence of cancer is only to small extent i.e., 9 in 10,000 people. It is not that much severe condition. So, researchers telling that cell phone usage do not cause brain tumors.<br />
But we have to mind that the radiation releases from mobiles and cordless phones are very dangerous. They can affect health of pregnant women. They also dangerous to children aged below 10 years.<br />
</div>
<div style="text-align: justify;">
<b>Effects of radiation:</b><br />
1. It affects pregnant health condition.<br />
2. Affects children health especially brains.<br />
3. Affects bird’s health.<br />
4. May causes some types of skin cancers.<br />
</div>
<div style="text-align: justify;">
So, we have to cautious about mobile usage. Especially pregnant women must use head phones while talking in mobiles. Parents never allow children(less than 10 years) to use mobiles more than 1 hour. Every one should use radition free mobiles to save ourselves from radiation. </div>
<div style="text-align: justify;">
<br /></div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="http://ecofrenglobal.blog.com/files/2011/06/mobile_radiations_danger_Funzug_org_01.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="http://ecofrenglobal.blog.com/files/2011/06/mobile_radiations_danger_Funzug_org_01.jpg" height="178" id="irc_mi" style="margin-top: 0px;" width="200" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Radiation is dangerous for children</b></td></tr>
</tbody></table>
<div style="text-align: justify;">
</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Steps to follow to protect ourselves from radiation:</b></div>
<div style="text-align: justify;">
1. Never sleep with mobile under your pillow. Keep mobile at least 10-20 meters away from head.</div>
<div style="text-align: justify;">
2. Always use left ear for mobile talking.</div>
<div style="text-align: justify;">
3. Never talk by mobile at the time of mobile charging.</div>
<div style="text-align: justify;">
4. Never talk by mobile when it is having low battery level (below 10%). At that time the radiation is 1000 times more than normal.</div>
<div style="text-align: justify;">
5. Never keep mobile near to vital organs like breast (especially female), heart, testis etc.,</div>
<div style="text-align: justify;">
<br /></div>
<br />
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
</div>
<div style="text-align: justify;">
</div>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgpTgz0cWur8gsPtKPhkCsDperPMosySt5g7x1ZbVWEE1m28c6Mp5CE6ClVttsJ5ONg2PzzKt0r6-oJMt_ru2s7T2ngqPlnSEEdPduI1s3KmtbFyK7Ud4MhpmUoZar8aFSNjH4vIjSLuYg/s1600/images.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgpTgz0cWur8gsPtKPhkCsDperPMosySt5g7x1ZbVWEE1m28c6Mp5CE6ClVttsJ5ONg2PzzKt0r6-oJMt_ru2s7T2ngqPlnSEEdPduI1s3KmtbFyK7Ud4MhpmUoZar8aFSNjH4vIjSLuYg/s1600/images.jpg" height="155" width="200" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Mobile radiation</b></td></tr>
</tbody></table>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Note:</b> Check your mobile radiation
by dialing *#07#. If it is less than 1.6 watt/kg its fine but if it is
not showing any thing after dialing *#07# then immediately change your
mobile as it is having more radiation that is why it is not showing any
thing.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-36518248812527637682015-01-14T05:13:00.001-08:002015-03-06T07:27:08.938-08:0010 MILLION PEOPLE WILL DIE WITH ANTIBIOTIC FAILURE BY THE YEAR 2050<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="http://pharmanewshub.blogspot.in/2014/12/in-india-antibiotic-prescription-became.html">http://pharmanewshub.blogspot.in/2014/12/in-india-antibiotic-prescription-became.html</a><!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>
<w:TrackFormatting/>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>EN-US</w:LidThemeOther>
<w:LidThemeAsian>X-NONE</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:DontVertAlignCellWithSp/>
<w:DontBreakConstrainedForcedTables/>
<w:DontVertAlignInTxbx/>
<w:Word11KerningPairs/>
<w:CachedColBalance/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><br />
<!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" Priority="39" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" Name="toc 9"/>
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
</w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-qformat:yes;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin-top:0in;
mso-para-margin-right:0in;
mso-para-margin-bottom:10.0pt;
mso-para-margin-left:0in;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
</style>
<![endif]-->
<br />
<div class="MsoNormal" style="text-align: justify;">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Anti
Microbial Resistance (AMR): </span></b></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span> </span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"> This is the condition in which the microbe
shows resistance to the respected antibiotics. It mean that the microbe will
not killed by antibiotic. This is also called as antibiotic failure.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Eg: Multi Drug
Resistance by bacteria <i style="mso-bidi-font-style: normal;">Mycobacterium
Tuberculae</i>.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span>Antibiotic resistance is the alarming future
disaster in all over the world. Antibiotic is one of the chemical compounds
that are developed to counteract bacteria, virus and all other microbes. </span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span>They
counteract microbes and kill them to protect body. Now a day’s means past from
20 years microbial infections occupies major part in disease conditions.
Simultaneously antibiotic use also increases. Physicians are prescribing more
antibiotics even for small diseases. Some physicians are prescribing strong
antibiotics. So the antibiotic resistance is developing in the present society
drastically. </span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span>Once one microbe will develops resistance it
never be killed by any antibiotic. So physicians should mind about this while
prescribing antibiotics. Any treatment for infections by antibiotics must start
with weak antibiotics. If that antibiotic dies not show action one should go
for another antibiotic. But never use strong antibiotic initially. Antibiotic
prescription needs evidence of culture sensitivity test. Prescribing antibiotic
without culture test is not a rational prescribing. </span></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span>Researchers and professionals telling that
antibiotic resistance will be the upcoming future disaster that the world
should face.<span style="mso-spacerun: yes;"> </span>It is the severe disaster
than all other diseases. So, we have to search ways to avoid this.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"></span>Till today 7,00,000 people are suffering from
AMR (Anti Microbial Resistance).</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">By the year 2050 it may
be 10 million.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Several diseases are
there that developing resistance to antibiotics. Some of them are,</span></div>
<br />
<ol style="text-align: left;">
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Cholera</span></li>
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Tuberculosis</span></li>
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";">
</span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Diarrhoea</span></li>
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";">Measles<span style="mso-list: Ignore;"></span></span></li>
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"></span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Tetanus etc.,</span></li>
</ol>
<br />
<div class="MsoNormal" style="text-align: justify;">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Reasons
for the development of AMR:</span></b></div>
<br />
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">The reasons may be;</span><br />
<ol style="text-align: left;">
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Using antibiotics without prescription.</span></li>
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Prescribing antibiotics without proper
evidence.</span></li>
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"></span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Prescribing strong antibiotics to small
infections.</span></li>
</ol>
<div class="MsoNormal" style="text-align: justify;">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Steps
to follow to avoid AMR:</span></b></div>
<ol style="text-align: left;">
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Should conduct culture sensitivity tests
before going to prescribe antibiotics.</span></li>
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Never use antibiotics without
prescription.</span></li>
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><img src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhI3qUXMnoyQKyEtRcZpy_1a1KbCtQVNr3Pln-hEroV4QU2Nq3O6V_ummyLIpakAorD7cvnC5E9sdEODBp0uoVOYIhieao5d-pHjjco5_1YbReciMEln1jLfWqRan_vr_QReGyXxp48KZcW/s1600/Culture+with+AB.jpg" height="291" id="irc_mi" style="margin-left: auto; margin-right: auto; margin-top: 51px;" width="433" /></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Culture sensitivity test</b></td></tr>
</tbody></table>
<li><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%; mso-fareast-font-family: "Times New Roman";"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"></span></span></span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Prescribe weak antibiotics initially.</span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"> </span></li>
</ol>
<div class="MsoListParagraphCxSpLast" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span></span></div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com1tag:blogger.com,1999:blog-2263144226565661782.post-60970087052065605272015-01-14T05:06:00.002-08:002015-03-06T07:21:48.064-08:00SWINE FLU RETURNS…..BE ALERT<div dir="ltr" style="text-align: left;" trbidi="on">
<!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>
<w:TrackFormatting/>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>EN-US</w:LidThemeOther>
<w:LidThemeAsian>X-NONE</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:DontVertAlignCellWithSp/>
<w:DontBreakConstrainedForcedTables/>
<w:DontVertAlignInTxbx/>
<w:Word11KerningPairs/>
<w:CachedColBalance/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><br />
<!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" Priority="39" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" Name="toc 9"/>
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
</w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-qformat:yes;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin-top:0in;
mso-para-margin-right:0in;
mso-para-margin-bottom:10.0pt;
mso-para-margin-left:0in;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
</style>
<![endif]-->
<br />
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">What is Swine flu:</b>
</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
It is one type of fever that is caused by Influenza virus.
There are 3 types in Influenza virus.</div>
<br />
<ol style="text-align: left;">
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"></span></span></span>A type</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span>B type<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span></li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";">
</span></span></span><span style="mso-spacerun: yes;"></span>C type</li>
</ol>
<br />
<div class="MsoNormal">
B and C are present in human beings. No need to worry about
these types. B type is present in humans, pigs and some birds. Swine flu
disease is first found in Mexico where more pig farms are maintaining. They
frequently use pork as their daily food. The virus present in pig was
interacted with the virus present in human and it leads to formation of severe
virus that is H1 N1 virus. This mechanism is called as Antigenic shift. This is
the causative organism of Swine flu. This virus first transfer from pig to
humans and again transmitted from human to human which became most dangerous
and communicable disease worldwide. </div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<img src="http://upload.wikimedia.org/wikipedia/commons/thumb/1/19/Swine_influenza_symptoms_on_swine-en.svg/2000px-Swine_influenza_symptoms_on_swine-en.svg.png" height="393" id="irc_mi" style="margin-top: 0px;" width="513" /> </div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">What is H1 N1:</b></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
Influenza virus contains 2 types of antigens- H and N. H
antigen again contains 9 types 1-9. N antigen contains 1-15 types. Among these
types of antigens any type can interact with any type and can form new antigens.
Here also happens the same thing. 1 type of H is combined with 9 type of N and
form H1N1 virus. </div>
<div class="MsoNormal">
H1N1- Swine flu virus</div>
<div class="MsoNormal">
H3N2- Flu virus</div>
<div class="MsoNormal">
H5n5- Bird flu virus</div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Modes of Transmission
of Swine flu:</b></div>
<ol style="text-align: left;">
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"></span></span>Swine flu can be transmitted from men to men
through droplets of infected person.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span>This virus will releases into air by the person
at the time of cough and sneeze.</li>
</ol>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;">Signs and Symptoms:</b></div>
<ol style="text-align: left;">
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span>Fever.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span>Headache.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span>Throat infection.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";">
</span></span></span>Body aches.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"></span></span>Sneezing.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"></span></span></span>Fatigue etc.,</li>
</ol>
<div class="MsoNormal" style="margin-left: 0.25in; text-align: left;">
<b>Diagnosis:</b> </div>
<div class="MsoNormal" style="margin-left: 0.25in; text-align: left;">
<br /></div>
<div class="MsoNormal" style="margin-left: 0.25in; text-align: left;">
Swine flu virus does not present
in blood samples. It is present in fluids of nose and mouth. This will be
collected by using ear bud and this will send for culture test.<b style="mso-bidi-font-weight: normal;"> </b></div>
<div class="MsoNormal" style="margin-left: 0.25in; text-align: left;">
<br /></div>
<div class="MsoNormal" style="margin-left: 0.25in; text-align: left;">
<b style="mso-bidi-font-weight: normal;">Current status of Swine flu:</b></div>
<br />
Today swine flu is not a severe
case because we have better treatment for this. In the year of 2009 and 2010
swine flu is a severe disease. But Researches and WHO is telling that, in
future swine flu will become as severe disease due to it modes of
transmission.<span style="mso-spacerun: yes;"> </span>That’s why we have to be
aware of this disease.
<br />
<div class="MsoNormal" style="margin-left: 0.25in; text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBrQiCOcDmzNOpMpQhdmenZVRLumZGtNOmqc1U6t09VV50GMUg0pmLQA4Mpfo_KijNWUidagnnFVo46i9FUFFsOH4zgbG6DUPkJsjLu1c7H6dSPtNW9TkywWky5i_8P_gUsjtWF_nxHl4/s1600/images.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBrQiCOcDmzNOpMpQhdmenZVRLumZGtNOmqc1U6t09VV50GMUg0pmLQA4Mpfo_KijNWUidagnnFVo46i9FUFFsOH4zgbG6DUPkJsjLu1c7H6dSPtNW9TkywWky5i_8P_gUsjtWF_nxHl4/s1600/images.jpg" /></a></div>
<div class="MsoNormal" style="margin-left: 0.25in; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-left: 0.25in; text-align: justify;">
<b style="mso-bidi-font-weight: normal;">Prevention methods:</b></div>
<ol style="text-align: left;">
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"></span></span></span>Isolation of patient.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span>Use mask when going into crowd areas.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"></span></span></span>Wash hands with hand wash after sneezing .</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"></span></span></span>Take proper diet.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt "Times New Roman";"> </span></span></span>Use medicines as physician advice.</li>
<li><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"></span></span>Swine flu Vaccination.</li>
</ol>
<div class="MsoListParagraphCxSpLast" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-left: .25in;">
<br /></div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com1tag:blogger.com,1999:blog-2263144226565661782.post-29511531310354889522015-01-12T00:05:00.002-08:002015-03-06T07:23:29.216-08:00Common Symptoms of Cancer in Females.<div dir="ltr" style="text-align: left;" trbidi="on">
<b>Cancer:</b><br />
<br />
Cancer is the condition in which normal body cells will grow abnormally that will appear as tumors. The developing cancers needs more nourishment than normal cells. So, they degrades body normal physiology. Final stage of cancer is fatal leads to death.<br />
<br />
Cancer is one of the fatal disease condition that increases day by day in modern world. There are 4 stages in the cancer based on severity of symptoms. If cancer detected in 1st or 2nd stage it will be cured by using chemo and radiation therapy in 50 to 80% of cases. The main drawback of cancer is the detection of symptoms. Because the symptoms are not recognized up to 3rd stage. In 3rd stage the survival rate is minimum. <br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjyp9fXgnLQlIfGRq435YOn1ucugkjiC8jb2AYrlLKRMt-EKwBiFNttJbhmGSFPptnVrP1WL2-nXwy_oB0d832aRy5floIszJN1YCZvqE6KiSsE1-D4c4nAbGA53Vq4t3IboBLsxCzkMa0/s1600/breast_self_exam4%5B1%5D_tcm8-78530.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjyp9fXgnLQlIfGRq435YOn1ucugkjiC8jb2AYrlLKRMt-EKwBiFNttJbhmGSFPptnVrP1WL2-nXwy_oB0d832aRy5floIszJN1YCZvqE6KiSsE1-D4c4nAbGA53Vq4t3IboBLsxCzkMa0/s1600/breast_self_exam4%5B1%5D_tcm8-78530.jpg" height="320" width="233" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Breast cancer- Self examination</b></td></tr>
</tbody></table>
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjRAsd3sdzXekKp5bF_vCI_XXVC6VKhxn2xlNTIHLJHHBNmBLEc3UOGbKhfHvbb5bMMlO0PWJYT4EmBJDesmUdz8-HMaKmPJqT5kUQwvByTapnlAHddnyDTAtY8w0sig6HLCzN15rUeWao/s1600/ovarian-cancer-s1-illustration-of-ovarian-cancer.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjRAsd3sdzXekKp5bF_vCI_XXVC6VKhxn2xlNTIHLJHHBNmBLEc3UOGbKhfHvbb5bMMlO0PWJYT4EmBJDesmUdz8-HMaKmPJqT5kUQwvByTapnlAHddnyDTAtY8w0sig6HLCzN15rUeWao/s1600/ovarian-cancer-s1-illustration-of-ovarian-cancer.jpg" height="217" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Ovarian cancer</b></td></tr>
</tbody></table>
<br />
<br />
But now a days several treatment options are available for treating cancer. The only need is to detect the symptoms at early stage. So, normal people need to educate about symptoms of cancer. Here, we are giving some common symptoms of cancer that one should not ignore this symptoms.<br />
<br />
They are,<br />
1. Changes in Breast size, shape:<br />
It may be the alarming sign for breast and ovarian cancer.<br />
<br />
2. Bloating:<br />
Females are common bloaters. But if excess bloating is there, you should consult gynecologist. It may be the symptom for ovarian cancer.<br />
<br />
3. Skin change:<br />
If the moles on skin getting changes in their size, color it may indicates skin cancer.<br />
<br />
4. Lymph node changes:<br />
Lymph nodes are commonly swells due to indications. But there is excessive swelling it may indicates Leukemia or Lymphoma.<br />
<br />
<br />
5. Swallowing difficulty:<br />
If there is difficulty in swallowing it may indicates throat cancer if you are smokers. Swallowing difficulty is also one of the symptoms of Parkinsonism disease.<br />
<br />
6. Fever:<br />
If you are suffering from fever frequently along with other symptoms of cancer it may indicates cancer.<br />
<br />
7. Heart burn:<br />
If you are frequently suffering from heart burn along with blood stains in stool it may indicates colon cancer.<br />
<br />
8. Blood in stools:<br />
If you observe blood in stools at the geriatric age it may indicates colon cancer. Never ignore it.<br />
<br />
9. Weight loss:<br />
If you are loosing weight with out trying it indicates any type of cancer. Weight loss is also a common symptom for several diseases like thyroid disorders, diabetes etc.,<br />
<br />
10. Mouth cahanges:<br />
If you are a smoker and if you observe any colour changes on lips or any ulcers in mouth, it may indicates oral cancer.<br />
<br />
11. Depression:<br />
Although depression is the symptom for psychic disorders, cancer patients also experience depression in some rare conditions.<br />
<br />
<br />
If you observe the above symptoms first you have to consult physician to relieve symptoms. If the symptoms do not relieve you should consult oncologist for cancer detection and treatment. <br />
<br /></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-86077415454137935182015-01-10T01:03:00.002-08:002015-03-05T23:09:46.127-08:00Safe and Effective Long-Acting Contraceptives LNG-IUS, ENG<div dir="ltr" style="text-align: left;" trbidi="on">
<b>Contraception:</b><br />
<br />
Contraception (birth control) prevents pregnancy by interfering with the
normal process of<br />
Ovulation<span style="color: black;"></span>,<br />
Fertilization and<br />
Implantation.<br />
There are
different kinds of birth control that act at different points in the
process.<br />
1. Contraceptives<br />
2. Condom and<br />
3. Tubal ligation<br />
<br />
<br />
<table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj2i_2Qc90kx-QZlNEaIFdfcZEaBmkKLLF4QWt-pQDaaaS918YuIQvCkOdR0w_zBo7PN-OaCL5goeS6dnFFsLhEn7jWbGu6TR9nK6s5ku4ZoDQZ6btVr6KJlc4lvETsTOiG3bQvDn40tkQ/s1600/mirena-iud.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj2i_2Qc90kx-QZlNEaIFdfcZEaBmkKLLF4QWt-pQDaaaS918YuIQvCkOdR0w_zBo7PN-OaCL5goeS6dnFFsLhEn7jWbGu6TR9nK6s5ku4ZoDQZ6btVr6KJlc4lvETsTOiG3bQvDn40tkQ/s1600/mirena-iud.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Intrauterine contraception</b></td></tr>
</tbody></table>
<br />
<span id="goog_1048857316"></span><span id="goog_1048857317"></span><br />
Every women ovaries releases one egg (ovum) that have the potency to fertilize when male sperm come into contact with it. If there is no availability of sperm as in case of absence of sexual intercourse the egg get excreted through menstruation.<br />
Now a days many young ladies wish to avoid pregnancy because of several reasons like<br />
1. Career plannings<br />
2. Health conciou<br />
3. Family planning<br />
4. Financial issues etc.,<br />
It is not easy to go for Abortion after conceiving. So, contraceptives is one of the great invention of modern era to avoid unwanted pregnancies. Now a days women depends on contraceptive methods to avoid pregnancy. But some are thinking that the contraceptive methods are not safe for long term use.<br />
<br />
Here, we have modern contraceptive methods which are safe on long term usage.<br />
1. Levonorgestrel Intrauterine System (LNG-IUS)<br />
2. Etonogestrel Sub dermal Implants (ENG) <br />
<br />
The researchers conducted study in U.S on long acting oral contraceptives found that the long term usage of LNG-IUS, ENG is safe. They also told that physicians has to counsel about the long term use of this contraceptives.Contraceptives are majorly used by young ladies aged 15-44 years in U.S.<br />
<br />
<b>Usage of LNG-IUS, ENG:</b><br />
LNG-IUS, ENG are implanted by physicians (Obstetrician and gyneocologists).<br />
<br />
<b>Side effects of LNG-IUS, ENG:</b><br />
No one medicine is safe without any side effects. contraceptives also involves some mild to moderate side effects as,<br />
1. Abnormal bleeding<br />
2. Uterine hemorrhage<br />
3. Cervicitis<br />
4. Excessive menstruation<br />
5. Rarely serious adverse effect like Pelvic inflammation.<br />
<br />
The failure of this contraceptive methods is less and some times no failure their pate at all.<br />
The researchers also told that physicians has to consel their patients about the effecs of contraceptives and in case of side effects they have to prescribe Doxicycline, tranexamic acid mifepristone combined with estrogen etc., to treat infections.<br />
<br />
Ultimately women has to use contraceptives under the supervision of physician to avoid serious side effects and patients has to monitor regularly for hormone levels. <br />
<br />
<br />
<br /></div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0tag:blogger.com,1999:blog-2263144226565661782.post-58299164784339507832015-01-09T00:04:00.003-08:002015-03-06T07:24:57.818-08:00Adding Whole grains to Daily food increases Life Expectancy <div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
<!--[if gte mso 9]><xml>
<o:OfficeDocumentSettings>
<o:RelyOnVML/>
<o:AllowPNG/>
</o:OfficeDocumentSettings>
</xml><![endif]--></div>
<div style="text-align: justify;">
<!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>
<w:TrackFormatting/>
<w:PunctuationKerning/>
<w:ValidateAgainstSchemas/>
<w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
<w:IgnoreMixedContent>false</w:IgnoreMixedContent>
<w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
<w:DoNotPromoteQF/>
<w:LidThemeOther>EN-US</w:LidThemeOther>
<w:LidThemeAsian>X-NONE</w:LidThemeAsian>
<w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
<w:Compatibility>
<w:BreakWrappedTables/>
<w:SnapToGridInCell/>
<w:WrapTextWithPunct/>
<w:UseAsianBreakRules/>
<w:DontGrowAutofit/>
<w:SplitPgBreakAndParaMark/>
<w:DontVertAlignCellWithSp/>
<w:DontBreakConstrainedForcedTables/>
<w:DontVertAlignInTxbx/>
<w:Word11KerningPairs/>
<w:CachedColBalance/>
</w:Compatibility>
<m:mathPr>
<m:mathFont m:val="Cambria Math"/>
<m:brkBin m:val="before"/>
<m:brkBinSub m:val="--"/>
<m:smallFrac m:val="off"/>
<m:dispDef/>
<m:lMargin m:val="0"/>
<m:rMargin m:val="0"/>
<m:defJc m:val="centerGroup"/>
<m:wrapIndent m:val="1440"/>
<m:intLim m:val="subSup"/>
<m:naryLim m:val="undOvr"/>
</m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267">
<w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
<w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
<w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
<w:LsdException Locked="false" Priority="39" Name="toc 1"/>
<w:LsdException Locked="false" Priority="39" Name="toc 2"/>
<w:LsdException Locked="false" Priority="39" Name="toc 3"/>
<w:LsdException Locked="false" Priority="39" Name="toc 4"/>
<w:LsdException Locked="false" Priority="39" Name="toc 5"/>
<w:LsdException Locked="false" Priority="39" Name="toc 6"/>
<w:LsdException Locked="false" Priority="39" Name="toc 7"/>
<w:LsdException Locked="false" Priority="39" Name="toc 8"/>
<w:LsdException Locked="false" Priority="39" Name="toc 9"/>
<w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
<w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/>
<w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
<w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
<w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
<w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
<w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
<w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
<w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
<w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
<w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
<w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
<w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
<w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/>
<w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
<w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
<w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
<w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
<w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
<w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
<w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
<w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
<w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/>
<w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
<w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
<w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
<w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
<w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
<w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
<w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
<w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
<w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
<w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
</w:LatentStyles>
</xml><![endif]--><!--[if gte mso 10]>
<style>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-qformat:yes;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin-top:0in;
mso-para-margin-right:0in;
mso-para-margin-bottom:10.0pt;
mso-para-margin-left:0in;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"Times New Roman";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
</style>
<![endif]-->
</div>
<div class="MsoNormal">
<br /></div>
<br />
<ul style="text-align: justify;">
<li><span style="font-family: "Times New Roman","serif";">Cardiovascular
diseases and diabetes risks are known to be decreased in the people who are
taking whole grains in their daily diet. In U.S very few people are taking
whole grains. </span></li>
<li><span style="font-family: "Times New Roman","serif";">100gms
of whole grains contain proteins equivalent to proteins present in 250gms of
red meat. In 2010 U.S people take only 24g of whole grains which is equal to
one whole grain bread slice. </span></li>
<li><span style="font-family: "Times New Roman","serif";">By taking other food material instead of whole
grains may increase incidence of cardiovascular risks. <table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiZsGp58PvHdYYZ2CppsVGef-cuVPGH1rzwVmPer_cI06S4AjI7sOQGgRH-8P81xNt3ZuGyqSCNH1LwK3OBEDqdhCwiycsKuuZE2t8cshFtD1rd04JAYGIdtGkV9m_hUvkmj6aa_72DK0k/s1600/HE_whole-grains_s4x3_lead.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiZsGp58PvHdYYZ2CppsVGef-cuVPGH1rzwVmPer_cI06S4AjI7sOQGgRH-8P81xNt3ZuGyqSCNH1LwK3OBEDqdhCwiycsKuuZE2t8cshFtD1rd04JAYGIdtGkV9m_hUvkmj6aa_72DK0k/s1600/HE_whole-grains_s4x3_lead.jpg" height="240" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><b>Whole Grains</b></td></tr>
</tbody></table>
</span></li>
</ul>
<div style="text-align: justify;">
</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "Times New Roman","serif";">Properties of whole grains:</span></b></div>
<div class="MsoNormal">
<br /></div>
<br />
<ul style="text-align: left;">
<li><span style="font-family: "Times New Roman","serif";">Whole
grains like wheat, corn, rye, oats and brown rice as well as barley, bulger,
buckwheat, popcorn, amaranth and as well as added bran or germ having
beneficial effect as its glycemic properties and nutrient contents are
different from other food material. </span></li>
<li><span style="font-family: "Times New Roman","serif";">The blood glucose and insulin levels are
less likely changed with whole grains unlike to refined grains. So, the
cardiovascular and diabetic risks are decreases.</span></li>
</ul>
<div style="text-align: justify;">
</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "Times New Roman","serif";">How to take whole grains in daily
food:</span></b></div>
<br />
<ol style="text-align: justify;">
<li><span style="font-family: "Times New Roman","serif";">Take
whole grains instead of snacks at evening times in the form of sprouts.</span></li>
<li><span style="font-family: "Times New Roman","serif";">Take
roti (chapatti) of whole grains instead of wheat roti.</span></li>
<li><span style="font-family: "Times New Roman","serif";"><span style="mso-spacerun: yes;"> </span>Take whole grain bread instead of milk bread.</span></li>
<li><span style="font-family: "Times New Roman","serif";">Use rice
bran oil in cooking instead of other edible oils. <table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto; text-align: center;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtwB0yKFSR3Fb0OVVXajIL4Db3gObA5rK7IUtbEUQrI1ie1_f81AoV_RoVqqDx5D94tWU7GH8JXHobdfNl-OaPd19Z6KQgDZN1aXrqhY2XUNkG3i-Cv4YEWPLUPYMIDilnOoKeuhpcSWU/s1600/Food-wholewheat-Masterfile2011.jpg" imageanchor="1" style="margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtwB0yKFSR3Fb0OVVXajIL4Db3gObA5rK7IUtbEUQrI1ie1_f81AoV_RoVqqDx5D94tWU7GH8JXHobdfNl-OaPd19Z6KQgDZN1aXrqhY2XUNkG3i-Cv4YEWPLUPYMIDilnOoKeuhpcSWU/s1600/Food-wholewheat-Masterfile2011.jpg" height="204" width="320" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Whole grain food</td></tr>
</tbody></table>
</span></li>
</ol>
<div style="text-align: justify;">
</div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "Times New Roman","serif";">Beneficial nutrients present in Whole
grains:</span></b></div>
<br />
<ol style="text-align: justify;">
<li><span style="font-family: "Times New Roman","serif";">Magnesium</span></li>
<li><span style="font-family: "Times New Roman","serif";">Vitamines</span></li>
<li><span style="font-family: "Times New Roman","serif";">Lignans</span></li>
<li><span style="font-family: "Times New Roman","serif";">Phenolic
acid and</span></li>
<li><span style="font-family: "Times New Roman","serif";">Alkylresorcinols.</span></li>
</ol>
<div style="text-align: justify;">
</div>
<div class="MsoListParagraph">
<br /></div>
<div class="MsoNormal">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "Times New Roman","serif";">Amazing facts of Whole grains:</span></b></div>
<br />
<ol style="text-align: justify;">
<li><span style="font-family: "Times New Roman","serif";">Properties
of Whole grains decrease the risk of cardiovascular diseases.</span></li>
<li><span style="font-family: "Times New Roman","serif";">Decreases
the risk of Diabetes.</span></li>
<li><span style="font-family: "Times New Roman","serif";">Maintain
Blood glucose levels within limits in diabetic patients.</span></li>
<li><span style="font-family: "Times New Roman","serif";">Maintain
cholesterol levels in obese patients.</span></li>
<li><span style="font-family: "Times New Roman","serif";">Give
more fiber to the body.</span></li>
</ol>
<div style="text-align: justify;">
</div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "Times New Roman","serif";">Note:</span></b><span style="font-family: "Times New Roman","serif";"> </span></div>
<br />
<ol style="text-align: left;">
<li><span style="font-family: "Times New Roman","serif";">Cardiovascular risk is decreased
by 9% with whole grains.</span></li>
<li><span style="font-family: "Times New Roman","serif";">Mortality
was decreased by 5% with whole grains.</span></li>
<li><span style="font-family: "Times New Roman","serif";">The
cancer risk is unchanged with Whole grains. </span></li>
</ol>
<div style="text-align: justify;">
</div>
<div class="MsoNormal" style="margin-left: 0.25in; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif";"><span style="mso-spacerun: yes;"> </span></span></div>
</div>
Anonymoushttp://www.blogger.com/profile/09339252196920616169noreply@blogger.com0